USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore

Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued at more than Rs. 200 crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2LAdNvW
via IFTTT